Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Welcure Drugs & PharmaceuticalsBOM:524661 -4.00%19 Interest Coverage is No Debt (1) as of Mar. 2026, which is 100% below its 10-year median of 550.00. GuruFocus rates BOM:524661 with a GF Score™ of 19/100. The stock has 5 warning signs investors should review. Among 89 Medical Distribution companies, Welcure Drugs & Pharmaceuticals ranks worse than 1123594.38% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Welcure Drugs & Pharmaceuticals's
Operating Income
for the
three
months ended in Mar. 2026 was ₹-499 Mil. Welcure Drugs & Pharmaceuticals's Interest Expense for the
three
months ended in Mar. 2026 was ₹0 Mil.
Welcure Drugs & Pharmaceuticals has no debt.
The higher the ratio, the stronger the company's financial strength is.
(1) Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
The historical rank and industry rank for Welcure Drugs & Pharmaceuticals's Interest Coverage or its related term are showing as below:
BOM:524661's Interest Coverage is not ranked *
in the Medical Distribution industry.
Industry Median: 6.23 * Ranked among companies with meaningful Interest Coverage only.
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Welcure Drugs & Pharmaceuticals Interest Coverage Related Terms
Welcure Drugs & Pharmaceuticals Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
BOM:524661 vs MCK, COR, CAH: Interest Coverage Comparison
For the Medical Distribution subindustry, Welcure Drugs & Pharmaceuticals's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Welcure Drugs & Pharmaceuticals Interest Coverage vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Welcure Drugs & Pharmaceuticals's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Welcure Drugs & Pharmaceuticals's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Interest Coverage of No Debt <sup>(1)</sup> mean?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a Interest Coverage of No Debt (1) as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. This is 100% below median its historical median of 550.00. Over the past decade, Welcure Drugs & Pharmaceuticals' Interest Coverage has ranged from 236.00 to 10,000.00. According to the industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #999999 out of 89 companies in the Medical Distribution industry.
Is Welcure Drugs & Pharmaceuticals' Interest Coverage too high?
Welcure Drugs & Pharmaceuticals' current Interest Coverage of No Debt (1) is 100% below median its 10-year median of 550.00. Over the past 10 years, this metric has ranged from a low of 236.00 to a high of 10,000.00. Based on the distribution chart, Welcure Drugs & Pharmaceuticals ranks #999999 out of 89 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Welcure Drugs & Pharmaceuticals has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Welcure Drugs & Pharmaceuticals' Interest Coverage compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Welcure Drugs & Pharmaceuticals ranks #999999 out of 89 companies for Interest Coverage. This places Welcure Drugs & Pharmaceuticals in the lower half of its industry. The industry median Interest Coverage is 6.23. Historically, Welcure Drugs & Pharmaceuticals' own Interest Coverage has ranged from 236.00 to 10,000.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Distribution company?
The median Interest Coverage among Medical Distribution companies is 6.23, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Welcure Drugs & Pharmaceuticals and its competitors. For the Medical Distribution industry, the median Interest Coverage is 6.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Welcure Drugs & Pharmaceuticals's current Interest Coverage is No Debt (1), which is 100% below median its own 10-year median of 550.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Welcure Drugs & Pharmaceuticals stock overvalued right now?
Welcure Drugs & Pharmaceuticals (BOM:524661) has a current Interest Coverage of No Debt (1). The current Interest Coverage is No Debt (1), which is 100% below median its 10-year median of 550.00. Welcure Drugs & Pharmaceuticals' overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Welcure Drugs & Pharmaceuticals (BOM:524661), the current Interest Coverage is No Debt (1) as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Welcure Drugs & Pharmaceuticals Business Description
Welcure Drugs & Pharmaceuticals Ltd is a pharmaceutical company. The company operates exclusively in a single business segment: the trading of medical products. The company's revenue is entirely derived from this segment, encompassing a range of activities from sourcing pharmaceutical products to facilitating their distribution in domestic and international markets.
19GF Score
Get the complete analysis for BOM:524661
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524661 has been successfully added to your 
